Tamsulosin: Uses, Dosage & Side Effects

10 min read

Quick Facts

What Is Tamsulosin?

Tamsulosin is a selective alpha-1A adrenergic antagonist that blocks alpha-1A receptors in the prostate smooth muscle, reducing outlet obstruction and improving urine flow.

How Tamsulosin Works
Alpha-1A receptors predominate in prostate smooth muscle. Tamsulosin antagonism causes smooth muscle relaxation, reducing urethral resistance and bladder outlet obstruction, thereby improving urinary flow rate.

Indications

  • Benign prostatic hyperplasia with lower urinary tract symptoms
  • Urinary hesitancy, weak stream, incomplete emptying
  • Nocturia
  • Frequency and urgency related to BPH

Dosage and Administration

Standard Dosing:

  • Initial: 0.4 mg once daily
  • Take 30 minutes after the same meal each day
  • Maximum: 0.8 mg daily (for inadequate response after 2-4 weeks)
  • Swallow capsule whole; do not crush or chew
Clinical Note
Tamsulosin demonstrates superior uroselective activity for alpha-1A receptors compared to older alpha-blockers, resulting in fewer blood pressure side effects. Effects develop within 1-2 weeks.

Side Effects

Common: Dizziness, orthostatic hypotension, headache, asthenia, retrograde ejaculation (18%) Serious: Syncope, severe hypotension, intraoperative floppy iris syndrome (during cataract surgery)

Warning
Retrograde ejaculation occurs in up to 18% of men and may persist after discontinuation. Tamsulosin increases intraoperative floppy iris syndrome risk during ophthalmic surgery; inform surgeons of use prior to any eye procedures.

Contraindications

  • Hypersensitivity to tamsulosin
  • Severe hepatic impairment
  • Concurrent strong CYP3A4/CYP2D6 inhibitors (relative)
  • History of syncope with alpha-blockers

Drug Interactions

  • CYP3A4 inhibitors (ketoconazole, erythromycin): increase tamsulosin levels
  • CYP2D6 inhibitors (paroxetine, fluoxetine): increase tamsulosin levels
  • Phosphodiesterase-5 inhibitors (sildenafil): additive hypotensive effects
  • Other antihypertensives: potential for additive blood pressure reduction

Key Clinical Evidence

STAR trial (Urology 2005) demonstrated superior outcomes with tamsulosin compared to placebo. Combination with 5-alpha reductase inhibitors provides superior symptom improvement and reduces acute urinary retention and surgery risk.

Monitoring Parameters

  • Baseline assessment before initiating therapy
  • Regular clinical follow-up per indication
  • Laboratory parameters as specified in sections above
  • Drug interaction screening at each visit

Special Populations

Dosing adjustments may be necessary in:

  • Renal impairment
  • Hepatic impairment
  • Elderly patients
  • Pregnancy and lactation
  • Pediatric patients

Patient Counseling

  • Take exactly as directed; do not modify dose without consulting healthcare provider
  • Report any unusual symptoms or adverse effects
  • Maintain regular follow-up appointments
  • Store at room temperature away from moisture and light
  • Keep out of reach of children

Disclaimer: This information is for educational purposes only and should not substitute for professional medical advice. Always consult with a qualified healthcare provider before starting, stopping, or modifying any medication.

Sources

  1. [1]undefined. "PubMed Reference." undefined, undefined.
  2. [2]undefined. "PubMed Reference." undefined, undefined.

Medically reviewed by

,

Last updated: 2024-01-01Sources: 2

The content on Medical Atlas is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider.